Heimdall Insights

Global Neutropenia Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Neutropenia Market was valued at $16.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.1% CAGR, to an estimated market size of $21.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global neutropenia market comprises the therapeutics and supportive care solutions used to manage neutropenia, a hematological condition defined by abnormally low levels of neutrophils. The scope includes treatments for chemotherapy-induced neutropenia (CIN), congenital neutropenia, and idiopathic forms, primarily utilizing granulocyte colony-stimulating factors (G-CSFs), antibiotics, and antifungal agents.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Neutropenia Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • Colony-Stimulating Factors (CSFs)
  • Antibiotics
  • Antifungals & Antivirals
  • Other Treatments